Optimal CAR T-cell Immunotherapy Strategies for a Leukemia Treatment Model
CAR T-cell immunotherapy is a new development in the treatment of leukemia, promising a new era in oncology. Although so far, this procedure only helps 50–90% of patients and, like other cancer treatments, has serious side effects. In this work, we have proposed a controlled model for leukemia treat...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-11-01
|
| Series: | Games |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4336/11/4/53 |